Sagittarius Life Science Corp (TPEX:3205)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
51.80
-0.30 (-0.58%)
Oct 9, 2025, 1:30 PM CST
-0.58%
Market Cap3.50B
Revenue (ttm)446.03M
Net Income (ttm)-54.24M
Shares Out67.55M
EPS (ttm)-1.49
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume166,445
Average Volume278,063
Open53.00
Previous Close52.10
Day's Range51.70 - 53.40
52-Week Range21.30 - 61.60
Beta0.71
RSI46.20
Earnings DateNov 13, 2025

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 112
Stock Exchange Taipei Exchange
Ticker Symbol 3205
Full Company Profile

Financial Performance

In 2024, Sagittarius Life Science's revenue was 467.75 million, an increase of 6.20% compared to the previous year's 440.46 million. Losses were -48.53 million, -11.82% less than in 2023.

Financial Statements

News

There is no news available yet.